DYN Dyne Therapeutics, Inc.
DYN Dyne Therapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
POC $18.16 · VWAP $19.55 · -20.1% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $65.2M sold last open-market sell Rhodes Jason P
Cluster CEO, CFO + 3 others sold $65.4M, Aug 17
Coverage
1 watchlist
DYN Price Structure
Loading timeframes…
Peers
Every watchlist DYN belongs to, members best 30-day change first — DYN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $-1.08 versus analyst consensus of $-0.75 (-44.3%).
full note →Against street estimates
How DYN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about DYN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 31 days ago · Sep 22
- Dyne Therapeutics (DYN) Stock Price & Overview
- Dyne Therapeutics (DYN) Stock Price, News & Analysis
- DYN earnings - Dyne Therapeutics Inc. earnings dates & releases | Quantisnow
- DYN Earnings - Dyne Therapeutics Inc. earnings announcements
- Dyne Therapeutics Inc Stock Price Today | NASDAQ: DYN Live - Investing.com
DYN research tape
36 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.